Brownsville R&D Tax Credit Explained for Businesses

R&D Tax Credits for Brownsville, Texas Businesses

Brownsville, Texas, thrives in industries such as healthcare, education, manufacturing, retail, and technology. Top companies in the city include Valley Baptist Medical Center, a leading healthcare provider; the University of Texas Rio Grande Valley, a major educational institution; SpaceX, a significant manufacturing employer; the Sunrise Mall, a key player in the retail sector; and SpaceX, a prominent technology company. The R&D Tax Credit can provide tax savings for these industries by incentivizing innovation and technological advancements.

find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 108 Wild Basin Rd South, Austin is less than 350 miles from Brownsville and provides R&D tax credit consulting and advisory services to Brownsville and the surrounding areas such as: Matamoros, Brownsville, Harlingen, McAllen and Edinburg.

If you have any questions or need further assistance, please call or email our local Austin Partner on (512) 333-2076.
Feel free to book a quick teleconference with one of our Texas R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Brownsville, Texas Patent of the Year – 2024/2025

Perumala Holdings, LLC has been awarded the 2024/2025 Patent of the Year for innovation in vaccine development. Their invention, detailed in U.S. Patent No. 11951164, titled ‘Systems and methods for the preparation of vaccines utilizing predictably inactivated pathogens’, offers a new approach to safely and effectively create vaccines.

This technology improves how pathogens are inactivated for vaccine production. It uses precise control over the inactivation process to ensure pathogens lose their harmful effects while keeping their structure intact. This balance helps the immune system recognize and respond to the vaccine more effectively.

By predicting and controlling the inactivation, the method enhances vaccine safety and consistency. It reduces risks linked to incomplete inactivation or damage to important pathogen features. The system is designed to work across different types of pathogens, making it adaptable for various vaccines.

The real-world impact of this invention includes faster, safer vaccine production and improved protection against infectious diseases. This method can streamline manufacturing and potentially lower costs, helping make vaccines more accessible globally. Perumala Holdings, LLC’s breakthrough could change how vaccines are developed, providing a vital tool in the fight against pandemics and other health threats.